Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-07

Clinical Trial Update: Lifemel Honey to Reduce Leucopenia During Chemotherapy [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating Lifemel Honey to reduce chemotherapy-induced leucopenia in breast cancer patients. The current status of the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lifemel Honey

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN